QQQ   354.95 (+0.84%)
AAPL   180.72 (+0.35%)
MSFT   336.69 (+1.24%)
META   273.15 (+0.20%)
GOOGL   125.07 (+1.09%)
AMZN   124.88 (+1.72%)
TSLA   215.64 (+3.91%)
NVDA   393.07 (-1.16%)
NIO   7.62 (+1.06%)
BABA   84.50 (+1.81%)
AMD   118.20 (-1.06%)
T   15.21 (-3.80%)
F   12.45 (+2.81%)
MU   69.24 (+0.22%)
CGC   0.82 (-1.52%)
GE   106.62 (+1.86%)
DIS   91.11 (+2.84%)
AMC   4.57 (+0.44%)
PFE   38.49 (+1.24%)
PYPL   64.03 (+1.55%)
NFLX   400.33 (-0.69%)
QQQ   354.95 (+0.84%)
AAPL   180.72 (+0.35%)
MSFT   336.69 (+1.24%)
META   273.15 (+0.20%)
GOOGL   125.07 (+1.09%)
AMZN   124.88 (+1.72%)
TSLA   215.64 (+3.91%)
NVDA   393.07 (-1.16%)
NIO   7.62 (+1.06%)
BABA   84.50 (+1.81%)
AMD   118.20 (-1.06%)
T   15.21 (-3.80%)
F   12.45 (+2.81%)
MU   69.24 (+0.22%)
CGC   0.82 (-1.52%)
GE   106.62 (+1.86%)
DIS   91.11 (+2.84%)
AMC   4.57 (+0.44%)
PFE   38.49 (+1.24%)
PYPL   64.03 (+1.55%)
NFLX   400.33 (-0.69%)
QQQ   354.95 (+0.84%)
AAPL   180.72 (+0.35%)
MSFT   336.69 (+1.24%)
META   273.15 (+0.20%)
GOOGL   125.07 (+1.09%)
AMZN   124.88 (+1.72%)
TSLA   215.64 (+3.91%)
NVDA   393.07 (-1.16%)
NIO   7.62 (+1.06%)
BABA   84.50 (+1.81%)
AMD   118.20 (-1.06%)
T   15.21 (-3.80%)
F   12.45 (+2.81%)
MU   69.24 (+0.22%)
CGC   0.82 (-1.52%)
GE   106.62 (+1.86%)
DIS   91.11 (+2.84%)
AMC   4.57 (+0.44%)
PFE   38.49 (+1.24%)
PYPL   64.03 (+1.55%)
NFLX   400.33 (-0.69%)
QQQ   354.95 (+0.84%)
AAPL   180.72 (+0.35%)
MSFT   336.69 (+1.24%)
META   273.15 (+0.20%)
GOOGL   125.07 (+1.09%)
AMZN   124.88 (+1.72%)
TSLA   215.64 (+3.91%)
NVDA   393.07 (-1.16%)
NIO   7.62 (+1.06%)
BABA   84.50 (+1.81%)
AMD   118.20 (-1.06%)
T   15.21 (-3.80%)
F   12.45 (+2.81%)
MU   69.24 (+0.22%)
CGC   0.82 (-1.52%)
GE   106.62 (+1.86%)
DIS   91.11 (+2.84%)
AMC   4.57 (+0.44%)
PFE   38.49 (+1.24%)
PYPL   64.03 (+1.55%)
NFLX   400.33 (-0.69%)
NYSE:RBOT

Vicarious Surgical (RBOT) Price Target & Analyst Ratings

$2.21
+0.01 (+0.45%)
(As of 03:03 PM ET)
Compare
Today's Range
$2.19
$2.28
50-Day Range
$1.90
$2.38
52-Week Range
$1.36
$4.76
Volume
104,094 shs
Average Volume
333,982 shs
Market Capitalization
$280.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Vicarious Surgical Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 1 Analyst Ratings

Consensus Analyst Price Target

$7.00
216.74% Upside
High Prediction$7.00
Average Prediction$7.00
Low Prediction$7.00
TypeCurrent
6/2/22 to 6/2/23
1 Month Ago
5/3/22 to 5/3/23
3 Months Ago
3/4/22 to 3/4/23
1 Year Ago
6/2/21 to 6/2/22
Consensus Rating
Buy
Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$7.00$6.00$6.00$12.75
Predicted Upside216.74% Upside72.74% Upside47.24% Upside44.11% Upside
Get Vicarious Surgical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.


RBOT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RBOT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Vicarious Surgical Stock vs. The Competition

TypeVicarious SurgicalMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.49
Consensus RatingBuyBuyHold
Predicted Upside209.73% Upside1,254.09% Upside200.82% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/18/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$8.00 ➝ $7.00+104.08%
(Data available from 6/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












RBOT Price Target - Frequently Asked Questions

What is Vicarious Surgical's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for Vicarious Surgical stock is Buy based on the current 1 buy rating for RBOT. The average twelve-month price prediction for Vicarious Surgical is $7.00 with a high price target of $7.00 and a low price target of $7.00. Learn more on RBOT's analyst rating history.

Do Wall Street analysts like Vicarious Surgical more than its competitors?

Analysts like Vicarious Surgical more than other Medical companies. The consensus rating score for Vicarious Surgical is 3.00 while the average consensus rating score for medical companies is 2.66. Learn more on how RBOT compares to other companies.

Does Vicarious Surgical's stock price have much upside?

According to analysts, Vicarious Surgical's stock has a predicted upside of 104.08% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NYSE:RBOT) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -